Abstract
e15719Background: Although overall survival (OS) benefit of adjuvant chemotherapy had been demonstrated in the CONKO-001 study, the application of it in daily practice of pancreatic cancer patients...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
